Influenza A M1 vaccine (Pascal Biosciences)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza A M1 vaccine (Pascal Biosciences)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionHLA-DR antigens-associated invariant chain agonists
TargetsHLA-DR antigens-associated invariant chain
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPascal Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesPascal Biosciences
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A